April 4 (Reuters) - Australian Competition and Consumer Commission (ACCC):
- WILL NOT OPPOSE REVISED COCHLEAR, OTICON TRANSACTION
- CONSIDERS IT UNLIKELY THAT OTICON MEDICAL WOULD HAVE BECOME A STRONGER COMPETITOR IN SUPPLY OF COCHLEAR IMPLANTS IN FORESEEABLE FUTURE
- SATISFIED THAT ITS COMPETITION CONCERNS WITH RESPECT TO BONE CONDUCTION SOLUTIONS ARE ADDRESSED
(([email protected];))
News: COH Australia's ACCC Says It Will Not Oppose Revised Cochlear, Oticon Transaction
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$318.37 |
Change
5.540(1.77%) |
Mkt cap ! $20.72B | |||
| Open | High | Low | Value | Volume |
| $314.28 | $318.72 | $313.71 | $6.821M | 21.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13 | $318.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $318.37 | 27 | 8 |
View Market Depth
| Last trade - 11.38am 28/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |